These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies. Fernandes PB, Swanson RN. Drugs Exp Clin Res; 1988; 14(6):375-8. PubMed ID: 3145851 [Abstract] [Full Text] [Related]
30. In vitro activity of fleroxacin and 6 other antimicrobials against Acinetobacter anitratus. Kropec A, Daschner F. Chemotherapy; 1989; 35(5):360-2. PubMed ID: 2507235 [Abstract] [Full Text] [Related]
36. In vitro activity of sparfloxacin compared with those of five other quinolones. Cantón E, Pemán J, Jimenez MT, Ramón MS, Gobernado M. Antimicrob Agents Chemother; 1992 Mar; 36(3):558-65. PubMed ID: 1320362 [Abstract] [Full Text] [Related]
38. In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone. Hosaka M, Yasue T, Fukuda H, Tomizawa H, Aoyama H, Hirai K. Antimicrob Agents Chemother; 1992 Oct; 36(10):2108-17. PubMed ID: 1332587 [Abstract] [Full Text] [Related]
39. In vitro activity of fleroxacin against aerobic gram-positive bacteria including Corynebacterium jeikeium. Hohl P, Felber AM. Chemotherapy; 1990 Oct; 36(6):403-6. PubMed ID: 2127242 [Abstract] [Full Text] [Related]
40. RO23-6240, a new orally absorbed quinolone: in vitro comparison with other broad-spectrum oral antimicrobial agents and imipenem. Aldridge KE, Schiro DD, Sanders CV. Diagn Microbiol Infect Dis; 1987 May; 7(1):9-19. PubMed ID: 3121244 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]